The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 183, 4887 -4894
Copyright © 2009 by The American Association of Immunologists, Inc.
doi:10.4049/jimmunol.0900363

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Google Scholar
Right arrow Articles by Chang, H.-C.
Right arrow Articles by Kaplan, M. H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chang, H.-C.
Right arrow Articles by Kaplan, M. H.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*UniGene
*Substance via MeSH

PU.1 Regulates TCR Expression by Modulating GATA-3 Activity1

Hua-Chen Chang,* Ling Han,* Rukhsana Jabeen,* Sebastian Carotta,{ddagger} Stephen L. Nutt,{ddagger} and Mark H. Kaplan2*{dagger}

*Department of Pediatrics, Herman B Wells Center for Pediatric Research; {dagger}Department of Microbiology and Immunology, Indiana University School of Medicine, Indianapolis, IN 46202; and {ddagger}The Walter and Eliza Hall Institute of Medical Research, Victoria, Australia

The Ets transcription factor PU.1 is a master regulator for the development of multiple lineages during hematopoiesis. The expression pattern of PU.1 is dynamically regulated during early T lineage development in the thymus. We previously revealed that PU.1 delineates heterogeneity of effector Th2 populations. In this study, we further define the function of PU.1 on the Th2 phenotype using mice that specifically lack PU.1 in T cells using an lck-Cre transgene with a conditional Sfpi1 allele (Sfpi1lck–/–). Although deletion of PU.1 by the lck-Cre transgene does not affect T cell development, Sfpi1lck–/– T cells have a lower activation threshold than wild-type T cells. When TCR engagement is limiting, Sfpi1lck–/– T cells cultured in Th2 polarizing conditions secrete higher levels of Th2 cytokines and have greater cytokine homogeneity than wild-type cells. We show that PU.1 modulates the levels of TCR expression in CD4+ T cells by regulating the DNA-binding activity of GATA-3 and limiting GATA-3 regulation of TCR gene expression. GATA-3-dependent regulation of TCR expression is also observed in Th1 and Th2 cells. In CD4+ T cells, PU.1 expression segregates into subpopulations of cells that have lower levels of surface TCR, suggesting that PU.1 contributes to the heterogeneity of TCR expression. Thus, we have identified a mechanism whereby increased GATA-3 function in the absence of the antagonizing activity of PU.1 leads to increased TCR expression, a reduced activation threshold, and increased homogeneity in Th2 populations.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by U.S. Public Health Service Award AI057459 (to M.H.K.) from the National Institutes of Health.

2 Address correspondence and reprint requests to Dr. Mark H. Kaplan, Department of Pediatrics, Indiana University School of Medicine, HB Wells Center for Pediatric Research, 702 Barnhill Drive RI2600, Indianapolis, IN 46202. E-mail address: mkaplan2{at}iupui.edu

3 Abbreviations used in this paper: shRNA, short hairpin RNA; ChIP, chromatin immunoprecipitation assay; DAPA, DNA affinity precipitation assay; DN, double negative; E, enhancer; hCD4, human CD4; MFI, mean fluorescent intensity; siRNA, small interfering RNA.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.